AMGEN (AMGN) Operating Margin (2008 - 2026)
AMGEN (AMGN) operating margin from Jun 30, 2008 to Mar 31, 2026. The current AMGEN (AMGN) operating margin is 30.94%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of AMGEN (AMGN)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 24.71% | +13.78% |
| 2024 | 21.71% | -22.48% |
| 2023 | 28.01% | -22.91% |
| 2022 | 36.34% | +23.59% |
| 2021 | 29.40% | -18.20% |
| 2020 | 35.95% | -13.19% |
| 2019 | 41.41% | -4.19% |
| 2018 | 43.22% | -0.98% |
| 2017 | 43.65% | +2.46% |
| 2016 | 42.60% | +8.95% |
| 2015 | 39.10% | +26.71% |
| 2014 | 30.86% | -1.77% |
| 2013 | 31.41% | -2.75% |
| 2012 | 32.30% | +16.73% |
| 2011 | 27.67% | -24.88% |
| 2010 | 36.84% | -2.04% |
| 2009 | 37.60% | +8.20% |
| 2008 | 34.75% | +28.98% |
| 2007 | 26.94% | N/A |
Comparison AMGEN (AMGN) operating margin with competitors
AMGEN (AMGN) operating margin is 30.94%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | +99.03% |
| GILD | Gilead Sciences Inc | 37.16% | +20.12% |
| NVS | Novartis AG | 31.31% | +1.21% |
| GSK | GSK Plc | 30.06% | -2.83% |
| AZN | Astrazeneca plc | 27.77% | -10.23% |
| ABBV | Abbvie Inc | 26.60% | -14.01% |
| JNJ | Johnson & Johnson | 26.58% | -14.08% |
| SNY | Sanofi | 20.18% | -34.77% |
| OGN | Organon & Company | 18.22% | -41.10% |
| GRFS | Grifols SA | 14.65% | -52.64% |